Work

Abstract CT243: Dirozalkib in patients with advanced ALK-positive non-small cell lung cancer (NSCLC): Results from a phase 2 study

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct243

Authors: Ying Liu, Yan Yu, Zhiye Zhang, Ruiling Ning, Yulan Sun, Meili Sun, Dairong Li, Li Wang, Xianghui Duan, Xuejie Guo, Yan Hu, Weili Liu, Haifeng Liu

Institutions: Jilin Province Tumor Hospital, Harbin Medical University, Henan University of Science and Technology, First Affiliated Hospital of Henan University of Science and Technology, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Shandong Tumor Hospital, Shandong First Medical University, Jinan Central Hospital, Chongqing University, Chongqing Cancer Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154707706

Cites:

Cited by:

Related to: